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Abstract
Introduction: The differential diagnosis of neutropenia includes medications, infections, autoimmune diseases, and
deficiencies of Vitamin B12 and folate. The association of Vitamin B6 deficiency with severe neutropenia is a rare
finding.
Case presentation: A 51-year-old Caucasian woman presented with fever and profound neutropenia (48
neutrophils/uL). Her clinical history included non-Hodgkin lymphoma, in remission following treatment with
allogeneic bone marrow transplantation, quiescent chronic graft-versus-host disease, and squamous cell carcinoma
of the skin metastatic to cervical lymph nodes. Medications included atenolol, topical clobetasol, Ditropan
(oxybutynin), prophylactic voriconazole, prophylactic valganciclovir, Soriatane (acitretin), and Carac (fluorouracil)
cream. The bone marrow was hypocellular without metastatic cancer or myelodysplasia. Neutropenia did not
respond to stopping medications that have been associated with neutropenia (valganciclovir, voriconazole and
Soriatane) or treatment with antibiotics or granulocyte colony stimulating factor. Blood tests revealed absence of
antineutrophil antibodies, normal folate and B12 levels, moderate zinc deficiency and severe Vitamin B6 deficiency.
Replacement therapy with oral Vitamin B6 restored blood vitamin levels to the normal range and corrected the
neutropenia. Her cervical adenopathy regressed clinically and became negative on scintography following Vitamin
B6 therapy and normalization of the blood neutrophil count.
Conclusion: Severe pyridoxine deficiency can lead to neutropenia. Screening for Vitamin B6 deficiency, along with
folate and Vitamin B12 levels, is recommended in patients with refractory neutropenia, especially those with
possible malabsorption syndromes, or a history of chronic-graft-versus host disease. Severe neutropenia may
facilitate progression of squamous cell carcinoma.
Introduction
Neutropenia has been associated with medications,
infections, autoimmune diseases, and deficiencies of
Vitamin B12 and folate [1]. An association of Vitamin
B6 deficiency with severe neutropenia is a rare finding
[2-4]. We describe the case of a patient who had severe
neutropenia (neutrophil count of 48 cells/uL) associated
with profound Vitamin B6 deficiency that markedly
improved with high dose Vitamin B6 therapy.
Case Presentation
The patient was a 51-year-old Caucasian woman with
relapsed non-Hodgkin lymphoma treated four years ear-
lier with an allogeneic stem cell transplant. Her lym-
phoma was in remission. Complications of her
allogeneic transplant included a history of chronic
extensive graft-versus-host disease (GvHD) involving the
skin and dermal squamous cell carcinoma. Immunosup-
pression with cyclosporine h a db e e nd i s c o n t i n u e dt w o
months earlier due to the development of squamous cell
carcinoma and the absence of active GvHD. She had no
history of smoking, alcohol, or drug abuse. She pre-
sented with fever and profound neutropenia; serial
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present for more than a month (Figure 1). Her examina-
tion showed moderate cachexia, long-standing scleroder-
matous changes and hyper-pigmentation of the skin
consistent with quiescent GvHD, palpable 2.5 cm left
cervical and submandibular adenopathy that was fluro-
deoxy glucose (FDG) avid on positron emission tomo-
graphy/computerized tomography (PET/CT) scan. She
had a non-focal neurological examination. A complete
blood count showed a normal total leukocyte count
(4,600/uL) with 2% granulocytes (48 neutrophils/uL)
together with 84% lymphocytes and 14% monocytes.
Red blood cells were 4.24 × 10E12/L, hemoglobin was
12.4 g/dL, hematocrit was 0.37, and the platelet count
was 113 × 10E9/L. Medications included atenolol, topi-
cal clobetasol, Ditropan (oxybutynin), prophylactic vori-
conazole, prophylactic valganciclovir, Soriatane
(acitretin), and Carac (fluorouracil) cream. Blood cul-
tures showed a micrococcus species. Her iron level was
330 mcg/L with 20% saturation. Folate, vitamin B1, vita-
min B12, copper, vitamin D levels, thyroid function
tests, creatinine, bilirubin, liver enzymes and lactate
dehydrogenase (LDH) were normal. Her blood zinc level
was borderline low at 49 mcg/dL. Antineutrophil anti-
bodies were absent (<1:10 titer). PCR tests for cytome-
galovirus (CMV) and Epstein Barr virus (EBV) in the
blood were negative, and had remained negative on pro-
phylactic doses of valganciclovir following CMV reacti-
vation five months earlier. Her vitamin B6 level was
very low at 0.5 ng/mL (reference range 5 to 30 ng/mL).
Serum IgG was polyclonally elevated at 3720 mg/dL as
were blood T-cells (4580 cells/uL) and CD8+ T-cells
(2836 cells/uL) with normal numbers of CD4+ T-cells,
B-cells and natural killer (NK) cells.
Her fever resolved with a course of vancomycin, with-
out identifying a site of infection. Histological examina-
tion of the marrow demonstrated marked
hypocellularity without specific megaloblastic or myelo-
dysplastic findings, metastatic cancer, or features to sug-
gest immune-mediated thrombocytopenia. Cytogenetic
analysis showed 100% donor (male) cells without any
clonotypic abnormalities. Biopsy of a cervical lymph
node showed poorly differentiated carcinoma, consistent
with metastatic squamous cell carcinoma. Valganciclo-
vir, voriconazole, and Soriatane (acitretin) were discon-
tinued (as potential causes of neutropenia) and
prophylactic fluconazole and acyclovir were started.
Granulocyte colony stimulating factor (G-CSF; 300 ug
subcutaneously every other day) was administered for
four doses in mid February 2010 without any improve-
ment in her neutropenia. Following daily supplementa-
tion with 150 mg Vitamin B6, blood B6 levels
normalized concomitant with resolution of the neutro-
penia (Figure 1). Following correction of the B6 defi-
ciency and neutropenia, the cervical adenopathy
completely regressed by clinical examination and
became scintographically negative by PET/CT.
Discussion
The differential diagnosis for neutropenia in our patient
includes drug effects, infection, the immune-suppressive
effects of chronic GvHD, autoimmunity [5], and a defi-
ciency of micronutrients [2-4]. Her neutropenia failed to
respond to discontinuation of drugs that have been
associated with neutropenia, was not associated with
recent CMV viremia or antineutrophil antibodies, and
was not associated with sepsis or a flare of her chronic
GvHD. Based on the clinical history of a rapid response
of neutropenia to high-dose Vitamin B6 replacement
therapy and a review of literature, we propose that this
case of neutropenia is most consistent with a deficiency
of Vitamin B6. Vitamin B6 treatment has been reported
to be effective in refractory neutropenia due to chronic
benzene, aspirin, sulfathiazole, and thiouracil exposure
[2-4]. The typical manifestations of Vitamin B6 defi-
ciency [6], including seborrhea dermatitis, intertrigo,
atrophic glossitis, angular chelitis, conjunctivitis, and
neurologic symptoms were not noted in our patient,
although depression was diagnosed and treated around
t h es a m et i m ea sn e u t r o p e n i aw a sn o t e d .S h ea l s oh a d
moderate thrombocytopenia. A micronutrient deficiency
may also have contributed to her thrombocytopenia,
although thrombocytopenia is common in patients with
extensive chronic GvHD. The cause of her profound
Vitamin B6 deficiency and moderate zinc deficiency was
Figure 1 Resolution of neutropenia and Vitamin B6 deficiency
following oral pyridoxine supplementation. The absolute
neutrophils per microliter blood are shown in open circles with a
solid line. The blood levels of Vitamin B6 are shown as filled
squares, with the dashed line. The duration of pyridoxine
administration (150 mg/day) is shown as the horizontal grey bars
(with a brief period of non-compliance in July). The administration
of 300 ug sub-cutaneous G-CSF every other day is shown with
asterisks.
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of the prior chronic GvHD.
Squamous cell carcinoma is a known complication of
cutaneous chronic GvHD and has been associated with
voriconazole therapy in patients receiving chronic
immune-suppressive drug therapy [7]. The regression of
squamous cell carcinoma that had metastasized to the
cervical lymph nodes following correction of neutrope-
nia may reflect the effect of stopping voriconazole and
immuno-suppressive drug therapy and/or the role of
innate immune responses to this cancer.
Conclusion
Vitamin B6 deficiency can be associated with neutrope-
nia. Screening for Vitamin B6 deficiency, along with
folate and vitamin B12 levels, is recommended in
patients with refractory neutropenia, especially those
with malabsorption syndromes, history of chronic
GvHD, or history of chronic benzene exposure.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
clinical data. A copy of the written consent is available
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